0770B |
Brompheniramine, Blood |
0770SP |
Brompheniramine, Serum/Plasma |
0770U |
Brompheniramine, Urine |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
0803B |
Bupropion and Metabolite, Blood |
0803FL |
Bupropion and Metabolite, Fluid |
0803SP |
Bupropion and Metabolite, Serum/Plasma |
0803TI |
Bupropion and Metabolite, Tissue |
0803U |
Bupropion and Metabolite, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
9118B |
Brompheniramine Screen, Blood |
9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |